Cargando…
Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793400/ https://www.ncbi.nlm.nih.gov/pubmed/36582794 http://dx.doi.org/10.3389/fonc.2022.1069999 |
_version_ | 1784859845683314688 |
---|---|
author | Zhao, Ni Yi, Ye Cao, Wen Fu, Xiao Mei, Nan Li, Chunli |
author_facet | Zhao, Ni Yi, Ye Cao, Wen Fu, Xiao Mei, Nan Li, Chunli |
author_sort | Zhao, Ni |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9793400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97934002022-12-28 Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy Zhao, Ni Yi, Ye Cao, Wen Fu, Xiao Mei, Nan Li, Chunli Front Oncol Oncology Frontiers Media S.A. 2022-12-13 /pmc/articles/PMC9793400/ /pubmed/36582794 http://dx.doi.org/10.3389/fonc.2022.1069999 Text en Copyright © 2022 Zhao, Yi, Cao, Fu, Mei and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhao, Ni Yi, Ye Cao, Wen Fu, Xiao Mei, Nan Li, Chunli Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy |
title | Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy |
title_full | Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy |
title_fullStr | Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy |
title_full_unstemmed | Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy |
title_short | Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy |
title_sort | corrigendum: serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793400/ https://www.ncbi.nlm.nih.gov/pubmed/36582794 http://dx.doi.org/10.3389/fonc.2022.1069999 |
work_keys_str_mv | AT zhaoni corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy AT yiye corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy AT caowen corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy AT fuxiao corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy AT meinan corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy AT lichunli corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy |